tyrphostin ag 1024 and daunorubicin

tyrphostin ag 1024 has been researched along with daunorubicin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kearns, P; Stankovic, T; Wei, W; Weston, VJ	1

Other Studies

1 other study(ies) available for tyrphostin ag 1024 and daunorubicin

Article	Year
Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1. Experimental hematology, 2018, Volume: 63 Topics: Butadienes; Cell Cycle; Chromones; Daunorubicin; Down-Regulation; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Humans; Intercellular Signaling Peptides and Proteins; MAP Kinase Kinase Kinase 1; Morpholines; Neoplasm Proteins; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Receptor, IGF Type 1; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT6 Transcription Factor; Tumor Cells, Cultured; Tyrphostins; Vincristine	2018

Article

Year

Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1.

Experimental hematology, 2018, Volume: 63

Topics: Butadienes; Cell Cycle; Chromones; Daunorubicin; Down-Regulation; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Humans; Intercellular Signaling Peptides and Proteins; MAP Kinase Kinase Kinase 1; Morpholines; Neoplasm Proteins; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Receptor, IGF Type 1; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT6 Transcription Factor; Tumor Cells, Cultured; Tyrphostins; Vincristine

2018